Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value
- PMID: 16093623
- DOI: 10.2463/mrms.3.79
Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value
Abstract
Purpose: The usefulness of diffusion-weighted imaging (DWI) in the field of neuroradiology has been established. Despite its high contrast resolution, DWI has the disadvantages of susceptibility artifact and chemical shift artifact. We performed DWI of breast cancer with the sensitivity encoding (SENSE) technique.
Methods: The subjects were 60 female patients with breast mass. All patients underwent MRI including SENSE-DWI and were diagnosed histologically. Of these patients, 55 were diagnosed with breast cancer and the remaining five were diagnosed with benign mass. The histological diagnoses of breast cancer were as follows: 39 cases of invasive ductal carcinoma (IDC); 11 cases of IDC with a predominant intraductal component and non IDC (pure or predominant NIDC); and five cases of special types of cancer. The MR system used was a Gyroscan Intera 1.5T (Philips Medical Systems). In addition to routine MRI for breast cancer, including contrast-enhanced dynamic, SENSE-DWI was obtained. The accuracy of the positional information of SENSE-DWI was visually compared with that of conventional images. The apparent diffusion coefficient (ADC) values of breast mass were analyzed with SENSE-DWI.
Results: The accuracy of positional information was adequate for diagnosing of all patients. The mean ADC value of breast cancer was 1.021x10(-3) mm2/s and that of benign mass was 1.488x10(-3) mm2/s (p=0.0002). The mean ADC value of IDC was 0.968x10(-3) mm2/s and that of pure or predominant NIDC was 1.218x10(-3) mm2/s (p=0.0011).
Conclusion: SENSE-DWI was of sufficient quality to support diagnosis of breast mass. SENSE-DWI may permit the acquisition of more detailed information about lesions, including tumor cellularity, that is difficult to obtain with conventional techniques.
Similar articles
-
ADC mapping of benign and malignant breast tumors.Magn Reson Med Sci. 2005;4(1):35-42. doi: 10.2463/mrms.4.35. Magn Reson Med Sci. 2005. PMID: 16127252 Clinical Trial.
-
Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.Acad Radiol. 2018 May;25(5):643-652. doi: 10.1016/j.acra.2017.11.011. Epub 2018 Jan 12. Acad Radiol. 2018. PMID: 29339079
-
Diffusion-weighted MR imaging of the breast: comparison of apparent diffusion coefficient values of normal breast tissue with benign and malignant breast lesions.Singapore Med J. 2012 Nov;53(11):737-43. Singapore Med J. 2012. PMID: 23192501
-
Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group.Eur Radiol. 2020 Mar;30(3):1436-1450. doi: 10.1007/s00330-019-06510-3. Epub 2019 Nov 30. Eur Radiol. 2020. PMID: 31786616 Free PMC article.
-
Usefulness of diffusion-weighted imaging and the apparent diffusion coefficient in the assessment of head and neck tumors.J Neuroradiol. 2008 May;35(2):71-8. doi: 10.1016/j.neurad.2008.01.080. Epub 2008 Mar 5. J Neuroradiol. 2008. PMID: 18325591 Review.
Cited by
-
MR mammography using diffusion-weighted imaging in evaluating breast cancer: a correlation with proliferation index.Radiol Med. 2015 Oct;120(10):911-8. doi: 10.1007/s11547-015-0527-z. Epub 2015 Mar 17. Radiol Med. 2015. PMID: 25776017
-
Comparison of diffusion-weighted images using short inversion time inversion recovery or chemical shift selective pulse as fat suppression in patients with breast cancer.Jpn J Radiol. 2009 May;27(4):163-7. doi: 10.1007/s11604-009-0314-7. Epub 2009 Jun 6. Jpn J Radiol. 2009. PMID: 19499306
-
Diffusion-weighted imaging of breast tumours at 3 Tesla and 7 Tesla: a comparison.Eur Radiol. 2016 May;26(5):1466-73. doi: 10.1007/s00330-015-3947-1. Epub 2015 Aug 27. Eur Radiol. 2016. PMID: 26310582
-
Diffusion-weighted magnetic resonance imaging for assessment after neoadjuvant chemotherapy in breast cancer, based on morphological concepts.Oncol Lett. 2010 Mar;1(2):293-298. doi: 10.3892/ol_00000052. Epub 2010 Mar 1. Oncol Lett. 2010. PMID: 22966297 Free PMC article.
-
Combining multiparametric MRI with receptor information to optimize prediction of pathologic response to neoadjuvant therapy in breast cancer: preliminary results.J Med Imaging (Bellingham). 2018 Jan;5(1):011015. doi: 10.1117/1.JMI.5.1.011015. Epub 2017 Dec 29. J Med Imaging (Bellingham). 2018. PMID: 29322067 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical